Recent Finacing
Recent Raise
ThirtyFiveBio develops small-molecule GPR35 inhibitors for gastrointestinal diseases and cancers, advancing multiple preclinical programs through IND-enabling studies from its Oxford, UK research operations.
Focus Areas
Recent Investors
Funding round
Investors
